[18F]-FMH3
- Generic Name
- [18F]-FMH3
Evaluation of [18F] FMH3 and PET as a Marker of Histamine-3 Receptor Activity in Subjects With AD Compared w/ HC
- First Posted Date
- 2010-12-29
- Last Posted Date
- 2013-11-11
- Lead Sponsor
- Institute for Neurodegenerative Disorders
- Target Recruit Count
- 5
- Registration Number
- NCT01268020
- Locations
- 🇺🇸
Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath